{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:03:19Z","timestamp":1761930199049,"version":"build-2065373602"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejim.2021.08.027","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T22:50:41Z","timestamp":1631659841000},"page":"15-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Popular procedures without evidence of benefit: A case study of percutaneous coronary intervention for stable coronary artery disease"],"prefix":"10.1016","volume":"94","author":[{"given":"Vinay","family":"Guduguntla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita F.","family":"Redberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ejim.2021.08.027_bib0001","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2016.06.33","article-title":"Epidemiology of coronary heart disease and acute coronary syndrome","volume":"4","author":"Sanchis-Gomar","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ejim.2021.08.027_bib0002","article-title":"Global epidemiology of ischemic heart disease: results from the global burden of disease study","author":"Khan","year":"2020","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.ejim.2021.08.027_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004080","article-title":"Angina and future cardiovascular events in stable patients with coronary artery disease: insights from the reduction of atherothrombosis for continued health (REACH) registry","volume":"5","author":"Eisen","year":"2016","journal-title":"JAHA"},{"issue":"25","key":"10.1016\/j.ejim.2021.08.027_bib0004","volume":"126","author":"Fihn","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ejim.2021.08.027_bib0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2019","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ejim.2021.08.027_bib0006","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM197907123010201","article-title":"Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty","volume":"301","author":"Gr\u00fcntzig","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2021.08.027_bib0007","article-title":"ORBITA: implications for regulatory review and coverage processes","author":"Redberg","year":"2018","journal-title":"Health Affairs Blog"},{"issue":"1","key":"10.1016\/j.ejim.2021.08.027_bib0008","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0002-8703(87)90974-4","article-title":"Ischemic heart disease: a patient-specific therapeutic approach with emphasis on quality of life considerations","volume":"114","author":"Scheidt","year":"1987","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ejim.2021.08.027_bib0009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1056\/NEJM199201023260102","article-title":"A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease","volume":"326","author":"Parisi","year":"1992","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejim.2021.08.027_bib0010","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1161\/01.CIR.92.7.1710","article-title":"A comparison of quality of life scores in patients with angina pectoris after angioplasty compared with after medical therapy: outcomes of a randomized clinical trial","volume":"92","author":"Strauss","year":"1995","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejim.2021.08.027_bib0011","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.68.5.939","article-title":"a randomized trial of coronary artery bypass surgery. Survival data","volume":"68","year":"1983","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ejim.2021.08.027_bib0012","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ejim.2021.08.027_bib0013","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A Randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","year":"2009","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ejim.2021.08.027_bib0014","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2021.08.027_bib0015","article-title":"Comparison of days alive out of hospital with initial invasive vs conservative management: a prespecified analysis of the ISCHEMIA trial","author":"White","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"22","key":"10.1016\/j.ejim.2021.08.027_bib0016","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.104.521864","article-title":"Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis","volume":"111","author":"Katritsis","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejim.2021.08.027_bib0017","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jamainternmed.2013.12855","article-title":"Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials","volume":"174","author":"Stergiopoulos","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.ejim.2021.08.027_bib0018","article-title":"Effects of percutaneous coronary intervention on death and myocardial infarction stratified by stable and unstable coronary artery disease: a meta-analysis of randomized controlled trials","volume":"13","author":"Chacko","year":"2020","journal-title":"Circ: Cardiovasc Qual Outcomes"},{"issue":"17","key":"10.1016\/j.ejim.2021.08.027_bib0019","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ejim.2021.08.027_bib0020","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","article-title":"Complete revascularization with multivessel PCI for myocardial infarction","volume":"381","author":"Mehta","year":"2019","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejim.2021.08.027_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008151","article-title":"Management of left main coronary artery disease","volume":"7","author":"Ramadan","year":"2018","journal-title":"JAHA"},{"issue":"17","key":"10.1016\/j.ejim.2021.08.027_bib0022","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2017.02.001","article-title":"ACC\/AATS\/AHA\/ASE\/ASNC\/SCAI\/SCCT\/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease","volume":"69","author":"Patel","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"10115","key":"10.1016\/j.ejim.2021.08.027_bib0023","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.ejim.2021.08.027_bib0024","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ejim.2021.08.027_bib0025","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1916374","article-title":"Health status after invasive or conservative care in coronary and advanced kidney disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejim.2021.08.027_bib0026","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa072771","article-title":"Effect of PCI on quality of life in patients with stable coronary disease","volume":"359","author":"Weintraub","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejim.2021.08.027_bib0027","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-year outcomes with PCI guided by fractional flow reserve","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.ejim.2021.08.027_bib0028","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1056\/NEJM197906213002508","article-title":"Angina pectoris and the placebo effect","volume":"300","author":"Bleich","year":"1979","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ejim.2021.08.027_bib0029","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJMp1406388","article-title":"Sham controls in medical device trials","volume":"371","author":"Redberg","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejim.2021.08.027_bib0030","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-152-6-201003160-00007","article-title":"Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief","volume":"152","author":"Wijeysundera","year":"2010","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2021.08.027_bib0031","first-page":"5","article-title":"Coronary arteriography 1984-1987: a report of the registry of the society for cardiac angiography and Interventions. I. Results and complications","volume":"17","author":"Johnson","year":"1989","journal-title":"Cathet Cardiovasc Diagn"},{"year":"2015","series-title":"Grossman & baim's cardiac catheterization, angiography, and intervention","author":"Moscucci","key":"10.1016\/j.ejim.2021.08.027_bib0032"},{"key":"10.1016\/j.ejim.2021.08.027_bib0033","unstructured":"Yugandhar M., Baradhi K. Cardiac catheterization risks and complications. Published online January 2020. Accessed September 27, 2020. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK531461\/."},{"issue":"18","key":"10.1016\/j.ejim.2021.08.027_bib0034","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.jacc.2010.02.005","article-title":"Contemporary mortality risk prediction for percutaneous coronary intervention","volume":"55","author":"Peterson","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ejim.2021.08.027_bib0035","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2019.11.058","article-title":"Stent-related adverse events >1 year after percutaneous coronary intervention","volume":"75","author":"Madhavan","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ejim.2021.08.027_bib0036","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jacc.2007.10.040","article-title":"Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions","volume":"51","author":"Ndrepepa","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2021.08.027_bib0037","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/CIRCINTERVENTIONS.109.928721","article-title":"Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years","volume":"3","author":"DT","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"issue":"18","key":"10.1016\/j.ejim.2021.08.027_bib0038","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jacc.2014.07.017","article-title":"2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease","volume":"64","author":"Fihn","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2021.08.027_bib0039","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.ejim.2021.08.027_bib0040","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa1915925","article-title":"Management of coronary disease in patients with advanced kidney disease","volume":"382","author":"Bangalore","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejim.2021.08.027_bib0041","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/CIRCOUTCOMES.108.798462","article-title":"Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients","volume":"1","author":"Weintraub","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"10.1016\/j.ejim.2021.08.027_bib0042","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/CIRCOUTCOMES.110.940502","article-title":"The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina","volume":"4","author":"Zhang","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"10.1016\/j.ejim.2021.08.027_bib0043","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2011.916","article-title":"Appropriateness of percutaneous coronary intervention","volume":"306","author":"Chan","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ejim.2021.08.027_bib0044","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jacc.2008.10.005","article-title":"ACCF\/SCAI\/STS\/AATS\/AHA\/ASNC 2009 appropriateness criteria for coronary revascularization","volume":"53","author":"Patel","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2021.08.027_bib0045","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ahj.2018.04.001","article-title":"Moving from volume to value for revascularization in stable ischemic heart disease: a review","volume":"204","author":"Gibbons","year":"2018","journal-title":"Am Heart J"},{"issue":"19","key":"10.1016\/j.ejim.2021.08.027_bib0046","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1001\/jama.2015.13764","article-title":"Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention","volume":"314","author":"Desai","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ejim.2021.08.027_bib0047","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.21326","article-title":"Trends in characteristics and outcomes of hospital inpatients undergoing coronary revascularization in the United States","volume":"3","author":"Alkhouli","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.ejim.2021.08.027_bib0048","article-title":"Upcoding of clinical information to meet appropriate use criteria for percutaneous coronary intervention","volume":"12","author":"Rajkumar","year":"2019","journal-title":"Circ: Cardiovasc Qual Outcomes"},{"issue":"2","key":"10.1016\/j.ejim.2021.08.027_bib0049","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jamainternmed.2018.5124","article-title":"Temporal trends in unstable angina diagnosis codes for outpatient percutaneous coronary interventions","volume":"179","author":"Wadhera","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ejim.2021.08.027_bib0050","article-title":"Trends in coded indications for percutaneous coronary interventions in medicare and the veterans affairs after implementation of hospital-level reporting of appropriate use criteria","author":"Dayoub","year":"2021","journal-title":"Circ: Cardiovasc Qual. Outcomes"},{"key":"10.1016\/j.ejim.2021.08.027_bib0051","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.3181","article-title":"Potential association of the ISCHEMIA trial with the appropriate use criteria ratings for percutaneous coronary intervention in stable ischemic heart disease","author":"Malik","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"16","key":"10.1016\/j.ejim.2021.08.027_bib0052","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1001\/archinte.167.16.1798","article-title":"Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study","volume":"167","author":"Gehi","year":"2007","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.ejim.2021.08.027_bib0053","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.amjmed.2013.01.033","article-title":"Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis","volume":"126","author":"Kumbhani","year":"2013","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.ejim.2021.08.027_bib0054","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamacardio.2017.2249","article-title":"Optimal medical therapy for known coronary artery disease: a review","volume":"2","author":"Gibbons","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"18","key":"10.1016\/j.ejim.2021.08.027_bib0055","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/jama.2011.601","article-title":"Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention","volume":"305","author":"Borden","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2021.08.027_bib0056","unstructured":"OECD Health Statistics 2020. Organisation for Economic Co-operation and Development, Accessed May 11, 2021. https:\/\/www.oecd.org\/health\/health-data.htm."},{"issue":"1","key":"10.1016\/j.ejim.2021.08.027_bib0057","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European Society of Cardiology: cardiovascular disease statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.ejim.2021.08.027_bib0058","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2459\/JCM.0000000000000835","article-title":"Percutaneous coronary interventions for stable ischemic heart disease in Italy","volume":"20","author":"De Servi","year":"2019","journal-title":"J Cardiovasc Med"},{"issue":"20","key":"10.1016\/j.ejim.2021.08.027_bib0059","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ejim.2021.08.027_bib0060","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/CIRCOUTCOMES.111.964320","article-title":"Appropriateness of percutaneous coronary interventions in Washington State","volume":"5","author":"Bradley","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"10","key":"10.1016\/j.ejim.2021.08.027_bib0061","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jacc.2016.12.025","article-title":"Changes in percutaneous coronary interventions deemed \u201cinappropriate\u201d by appropriate use criteria","volume":"69","author":"Hannan","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2021.08.027_bib0062","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1540-8183.2002.tb01071.x","article-title":"The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions","volume":"15","author":"Moscucci","year":"2002","journal-title":"J Interven Cardiology"},{"issue":"6","key":"10.1016\/j.ejim.2021.08.027_bib0063","first-page":"672","article-title":"Hypothetical ratings of coronary angiography appropriateness: are they associated with actual angiographic findings, mortality, and revascularisation rate?","volume":"85","author":"Hemingway","year":"2001","journal-title":"ACRE study. Heart"},{"issue":"8","key":"10.1016\/j.ejim.2021.08.027_bib0064","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/M14-1889","article-title":"Validation of the appropriate use criteria for coronary angiography: a cohort study","volume":"162","author":"Mohareb","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2021.08.027_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcha.2020.100677","article-title":"Appropriate use criteria for coronary angiography: a single centre experience","volume":"31","author":"Silenzi","year":"2020","journal-title":"IJC Heart Vasculature"},{"key":"10.1016\/j.ejim.2021.08.027_bib0066","doi-asserted-by":"crossref","unstructured":"Howard D.H., Desai N.R. US false claims act investigations of unnecessary percutaneous coronary interventions. JAMA Intern Med. Published online September 21, 2020. doi:10.1001\/jamainternmed.2020.2812.","DOI":"10.1001\/jamainternmed.2020.2812"},{"issue":"Winter","key":"10.1016\/j.ejim.2021.08.027_bib0067","article-title":"Development of a catheterization and percutaneous coronary intervention registry with a data management approach: a systematic review","volume":"16","author":"Tabrizi","year":"2019","journal-title":"Perspect Health Inf Manag"},{"key":"10.1016\/j.ejim.2021.08.027_bib0068","doi-asserted-by":"crossref","unstructured":"Figulla H.R., Lauten A., Maier L.S., Sechtem U., Silber S., Thiele H. Percutaneous coronary intervention in stable coronary heart disease \u2014is less more? Deutsches aerzteblatt online. Published online February 28, 2020. doi:10.3238\/arztebl.2020.0137.","DOI":"10.3238\/arztebl.2020.0137"},{"issue":"8","key":"10.1016\/j.ejim.2021.08.027_bib0069","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.amjcard.2016.01.025","article-title":"Cost savings associated with implementation of peer-reviewed appropriate use criteria for percutaneous coronary interventions","volume":"117","author":"Puri","year":"2016","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.ejim.2021.08.027_bib0070","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014738","article-title":"Multidisciplinary heart team approach for complex coronary artery disease: single center clinical presentation","volume":"9","author":"Young","year":"2020","journal-title":"JAHA"},{"issue":"9","key":"10.1016\/j.ejim.2021.08.027_bib0071","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016909","article-title":"APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: the APACHE pilot study","volume":"7","author":"Leonardi","year":"2017","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.ejim.2021.08.027_bib0072","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jamainternmed.2014.3328","article-title":"How cardiologists present the benefits of percutaneous coronary interventions to patients with stable angina: a qualitative analysis","volume":"174","author":"Goff","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"15","key":"10.1016\/j.ejim.2021.08.027_bib0073","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1001\/archinte.167.15.1604","article-title":"Cardiologists\u2019 use of percutaneous coronary interventions for stable coronary artery disease","volume":"167","author":"Lin","year":"2007","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.ejim.2021.08.027_bib0074","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.pec.2017.01.010","article-title":"PCI Choice: cardiovascular clinicians\u2019 perceptions of shared decision making in stable coronary artery disease","volume":"100","author":"Coylewright","year":"2017","journal-title":"Patient Educ. Counsel"},{"issue":"5","key":"10.1016\/j.ejim.2021.08.027_bib0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-153-5-201009070-00005","article-title":"Patients\u2019 and cardiologists\u2019 perceptions of the benefits of percutaneous coronary intervention for stable coronary disease","volume":"153","author":"Rothberg","year":"2010","journal-title":"Ann Intern Med"},{"year":"2018","series-title":"In Focus: physician-led efforts to promote value","author":"Hostetter","key":"10.1016\/j.ejim.2021.08.027_bib0076"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620521003009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620521003009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:34:48Z","timestamp":1760607288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620521003009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":76,"alternative-id":["S0953620521003009"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2021.08.027","relation":{},"ISSN":["0953-6205"],"issn-type":[{"type":"print","value":"0953-6205"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Popular procedures without evidence of benefit: A case study of percutaneous coronary intervention for stable coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2021.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}